Comparison of functioning and health-related quality of life among patients with HTLV-1, HIV, and HIV-HTLV-1-coinfection
- PMID: 33759928
- PMCID: PMC8008869
- DOI: 10.1590/0037-8682-0759-2020
Comparison of functioning and health-related quality of life among patients with HTLV-1, HIV, and HIV-HTLV-1-coinfection
Abstract
Introduction: Human immunodeficiency virus (HIV) and human T-cell leukemia virus-1 (HTLV-1) viruses are associated with a high global burden of disease, and coinfection is a frequently reported event. We aimed to compare the functioning and health-related quality of life (HRQoL) of patients infected with HTLV-1, HIV, and HIV-HTLV-1.
Methods: We conducted a cross-sectional study of patients older than 18 years who had an HTLV-1 infection (Group A), HIV infection (Group B), or HIV-HTLV-1 coinfection (Group C). The functioning profiles were evaluated using handgrip strength, Berg balance scale (BBS), timed "up and go" (TUG) test, and 5-m walk test (m/s). We used the World Health Organization Disability Assessment Schedule (WHODAS 2.0) questionnaire to measure disability. The HRQoL was evaluated using a 36-item short-form health survey. For data with parametric and non-parametric distribution, we used analysis of variance with Bonferroni correction and the Kruskal-Wallis test, followed by Dunn's pairwise tests with Bonferroni correction.
Results: We enrolled 68 patients in Group A, 39 in Group B, and 29 in Group C. The scores for handgrip strength, BBS, TUG test, all the WHODAS domains, and HRQoL were poorer for Groups A and C than for Group B.
Conclusions: Compared to patients with HIV infection, those with HIV-HTLV-1 coinfection and HTLV-1 infection had poor functioning and HRQoL scores. HTLV-1 infection was associated with reduced functioning and HRQoL in patients with a single HTLV-1 infection and HIV-HTLV-1 coinfection.
Conflict of interest statement
Similar articles
-
Human T-lymphotropic Virus Co-infections in Adults Infected With Human Immunodeficiency Virus.Am J Med Sci. 2016 Sep;352(3):258-60. doi: 10.1016/j.amjms.2016.05.023. Epub 2016 May 27. Am J Med Sci. 2016. PMID: 27650229
-
Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.AIDS Rev. 2007 Jul-Sep;9(3):140-9. AIDS Rev. 2007. PMID: 17982939 Review.
-
Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.mSphere. 2018 Apr 4;3(2):e00038-18. doi: 10.1128/mSphere.00038-18. Print 2018 Apr 25. mSphere. 2018. PMID: 29624497 Free PMC article.
-
Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.Clin Infect Dis. 2007 May 1;44(9):1229-34. doi: 10.1086/513428. Epub 2007 Mar 19. Clin Infect Dis. 2007. PMID: 17407044
-
Coinfection with HTLV-I and HIV: increase in HTLV-I-related outcomes but not accelerated HIV disease progression?AIDS Patient Care STDS. 1998 Aug;12(8):619-23. doi: 10.1089/apc.1998.12.619. AIDS Patient Care STDS. 1998. PMID: 15468433 Review.
Cited by
-
Immunological and Neurological Signatures of the Co-Infection of HIV and HTLV: Current Insights and Future Perspectives.Viruses. 2025 Apr 8;17(4):545. doi: 10.3390/v17040545. Viruses. 2025. PMID: 40284988 Free PMC article. Review.
-
Work ability and associated factors in people living with human T-cell leukemia virus type 1.Rev Soc Bras Med Trop. 2022 Aug 5;55:e0111. doi: 10.1590/0037-8682-0111-2022. eCollection 2022. Rev Soc Bras Med Trop. 2022. PMID: 35946625 Free PMC article.
References
-
- Brites C, Sampalo J, Oliveira A. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev. 2009;11(1):8–16. - PubMed
-
- Bahia F, Novais V, Evans J, Le Marchand C, Netto E, Page K, et al. The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus. J Acquir Immune Defic Syndr. 2011;57(Suppl 3)(03):S202–S207. doi: 10.1097/QAI.0b013e31821e9a1e. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical